Stock Track | 4DMedical Soars 8.00% Intraday on Positive Study Results for CT:VQ Imaging Product

Stock Track
May 19

4DMEDICAL LTD (ASX:4DX) saw its shares soar 8.00% during intraday trading on Tuesday, following the announcement of positive clinical study results.

The surge comes after the company disclosed that a study published in the American Journal of Respiratory and Critical Care Medicine demonstrated its CT:VQ imaging product could significantly improve patient selection for lung volume reduction surgery. The study showed that using CT:VQ guidance would deliver a 76% response rate to the surgery, compared to the current rate of 46%.

This improvement in pre-operative selection is expected to strengthen the economics of surgical programs for hospitals by focusing resources on patients most likely to benefit, potentially driving increased adoption of 4DMedical's technology.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10